Literature DB >> 25034527

Interaction of PTPRO and TLR4 signaling in hepatocellular carcinoma.

Donghua Xu1, Xiaochen Wang, Shushan Yan, Yin Yin, Jiajie Hou, Xuehao Wang, Beicheng Sun.   

Abstract

Protein tyrosine phosphatase receptor type O (PTPRO) has been identified as a tumor suppressor in a number of cancers including hepatocellular carcinoma (HCC). Toll-like receptor 4 (TLR4) plays diverse roles in HCC tumorigenesis and progression. The association between PTPRO and TLR4 signaling in HCC remains largely unknown. We aimed to clarify the interaction between PTPRO and TLR4 in HCC. Surprisingly, we found reduced and positive-related expression of TLR4 and PTPRO in 84 human HCC specimens. Increased TLR4 expression and activity was found in PTPRO-overexpressed HCC cells stimulated with lipopolysaccharide (LPS). The feedback regulation of PTPRO and TLR4 was dependent on nuclear factor-κB (NF-κB) activation, as suggested by NF-κB inhibition and luciferase reporter assay. Our study suggests that the effect of PTPRO on TLR4 signaling is dependent on NF-κB pathway, suggesting an interesting PTPRO/TLR4/NF-κB signaling feedback loop in HCC carcinogenesis and progression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25034527     DOI: 10.1007/s13277-014-2302-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  31 in total

1.  Protein tyrosine phosphatase receptor-type O truncated (PTPROt) regulates SYK phosphorylation, proximal B-cell-receptor signaling, and cellular proliferation.

Authors:  Linfeng Chen; Przemyslaw Juszczynski; Kunihiko Takeyama; Ricardo C T Aguiar; Margaret A Shipp
Journal:  Blood       Date:  2006-08-03       Impact factor: 22.113

2.  Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice.

Authors:  Ziyan Wang; Jun Yan; Heng Lin; Fang Hua; Xiaoxing Wang; Hanzhi Liu; Xiaoxi Lv; Jiaojiao Yu; Su Mi; Jiaping Wang; Zhuo-Wei Hu
Journal:  Hepatology       Date:  2013-04-05       Impact factor: 17.425

3.  Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.

Authors:  Dianne H Dapito; Ali Mencin; Geum-Youn Gwak; Jean-Philippe Pradere; Myoung-Kuk Jang; Ingmar Mederacke; Jorge M Caviglia; Hossein Khiabanian; Adebowale Adeyemi; Ramon Bataller; Jay H Lefkowitch; Maureen Bower; Richard Friedman; R Balfour Sartor; Raul Rabadan; Robert F Schwabe
Journal:  Cancer Cell       Date:  2012-04-17       Impact factor: 31.743

4.  Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents.

Authors:  Le-Xing Yu; He-Xin Yan; Qiong Liu; Wen Yang; Hong-Ping Wu; Wei Dong; Liang Tang; Yan Lin; Ya-Qin He; Shan-Shan Zou; Chao Wang; Hui-Lu Zhang; Guang-Wen Cao; Meng-Chao Wu; Hong-Yang Wang
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

5.  Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Diego F Calvisi; Sara Ladu; Alexis Gorden; Miriam Farina; Ju-Seog Lee; Elizabeth A Conner; Insa Schroeder; Valentina M Factor; Snorri S Thorgeirsson
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

6.  The significance of Toll-like receptor 4 (TLR4) expression in patients with chronic hepatitis B.

Authors:  Xiu-Qing Wei; Yun-Wei Guo; Jia-Jun Liu; Zhuo-Fu Wen; Shao-Ji Yang; Ji-Lu Yao
Journal:  Clin Invest Med       Date:  2008       Impact factor: 0.825

7.  Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.

Authors:  Willscott E Naugler; Toshiharu Sakurai; Sunhwa Kim; Shin Maeda; Kyounghyun Kim; Ahmed M Elsharkawy; Michael Karin
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

8.  Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population.

Authors:  Pengchao Li; Jinbao Gu; Xiao Yang; Hongzhou Cai; Jun Tao; Xuejian Yang; Qiang Lu; Zengjun Wang; Changjun Yin; Min Gu
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

9.  PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy.

Authors:  Yi-Teng Huang; Fei-Fei Li; Chen Ke; Zhou Li; Zong-Tai Li; Xiao-Fang Zou; Xiao-Xuan Zheng; Yu-Ping Chen; Hao Zhang
Journal:  J Transl Med       Date:  2013-10-03       Impact factor: 5.531

Review 10.  Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers.

Authors:  Chun Wai Mai; Yew Beng Kang; Mallikarjuna Rao Pichika
Journal:  Onco Targets Ther       Date:  2013-11-05       Impact factor: 4.147

View more
  6 in total

1.  The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice.

Authors:  Isabelle Jingyi Song; Yoon Mee Yang; Sayaka Inokuchi-Shimizu; Yoon Seok Roh; Ling Yang; Ekihiro Seki
Journal:  Int J Cancer       Date:  2017-09-23       Impact factor: 7.396

2.  Genome-Wide Association Study of Fluorescent Oxidation Products Accounting for Tobacco Smoking Status in Adults from the French EGEA Study.

Authors:  Laurent Orsi; Patricia Margaritte-Jeannin; Miora Andrianjafimasy; Orianne Dumas; Hamida Mohamdi; Emmanuelle Bouzigon; Florence Demenais; Régis Matran; Farid Zerimech; Rachel Nadif; Marie-Hélène Dizier
Journal:  Antioxidants (Basel)       Date:  2022-04-20

Review 3.  Innate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis?

Authors:  Jorge André Gomes Lopes; Marta Borges-Canha; Pedro Pimentel-Nunes
Journal:  World J Hepatol       Date:  2016-01-28

4.  PTPRO knockdown protects against inflammation in hemorrhage shock-induced lung injury involving the NF-κB signaling pathway.

Authors:  Zhirong Huan; Ying Tang; Ce Xu; Jimin Cai; Hao Yao; Yan Wang; Fanyu Bu; Xin Ge
Journal:  Respir Res       Date:  2022-07-29

5.  LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway.

Authors:  X Wang; W Zhang; J Tang; R Huang; J Li; D Xu; Y Xie; R Jiang; L Deng; X Zhang; Y Chai; X Qin; B Sun
Journal:  Cell Death Dis       Date:  2016-03-03       Impact factor: 8.469

Review 6.  The Roles of Protein Tyrosine Phosphatases in Hepatocellular Carcinoma.

Authors:  Yide Huang; Yafei Zhang; Lilin Ge; Yao Lin; Hang Fai Kwok
Journal:  Cancers (Basel)       Date:  2018-03-20       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.